WebDr. Felicitas Thol, is an Internal Medicine specialist practicing in LEBANON, NH with 19 years of experience. . New patients are welcome. Find Providers by Specialty ... Dr. Thol … WebSep 18, 2024 · 2.1. Cohort Analysis. A total of 29 patients were recruited to this prospective observational study, of whom 21 met the inclusion criteria. Nine healthy subjects served as the control group (Figure 1).Patient characteristics and details on DLI treatment are given in Supplementary Tables S1 and S2.Healthy controls’ characteristics are shown in …
Posttransplantation MRD monitoring in patients with AML by next ...
WebJun 1, 2024 · Europe PMC is an archive of life sciences journal literature. Search life-sciences literature (Over 40 million articles, preprints and more) WebMar 1, 2024 · Europe PMC is an archive of life sciences journal literature. inspirational office
Midostaurin plus intensive chemotherapy for younger and older …
WebJun 13, 2011 · Purpose To study the incidence and prognostic impact of mutations in DNA methyltransferase 3A (DNMT3A) in patients with acute myeloid leukemia. Patients and Methods A total of 489 patients with AML were examined for mutations in DNMT3A by direct sequencing. The prognostic impact of DNMT3A mutations was evaluated in the context … WebDec 10, 2024 · Correspondence Felicitas Thol, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Str 1, … WebJun 29, 2024 · Wagner K, Damm F, Thol F, Gohring G, Gorlich K, Heuser M, et al. FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype. Haematologica. 2011; 96 (5):681–686. doi: 10.3324/haematol.2010.034074. [Europe PMC free article] [Google … jesus called herod a fox